Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...
Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...
Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
Diabetes mellitus is a metabolic disease that causes high blood sugar. Your body either doesn’t make enough insulin or can’t effectively use the insulin it makes. The hormone insulin moves ...
With CE Mark approval, the benefits of the MiniMedâ„¢ 780G system are now available with a new sensor that takes less than 10 seconds to insert 1 The MiniMed 780G system with Simplera Syncâ„¢ sensor will ...
Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...